Literature DB >> 2649327

Unbiased and flexible iterative computer program to achieve glucose clamping.

D R Matthews1, J P Hosker.   

Abstract

Glucose clamping has become a widely used test for assessing insulin sensitivity and beta-cell function. We present a new method of achieving a reliable and unbiased clamp using an iterative computer program. After initial parameter estimation, the program uses no fixed algorithm or physiological preconceptions but makes predictions according to previous glycemic responses to infusion rates. The program can be used for human or animal studies and for euglycemic or hyperglycemic clamps. The program has flexible data entry, graphic display, running statistics of mean infusion data, and mean glucose levels and their standard deviations. These form part of the criteria for the assessment of glucose clamping, which includes the sampling interval, the duration of the clamp, the achieved glucose concentration (together with its coefficient of variation), and the percent change of glucose infused at the end of the clamp. Data for 151 consecutive clamp studies were analyzed. Median coefficient of variation of glucose values at the end of the clamp was 2%.

Entities:  

Mesh:

Year:  1989        PMID: 2649327     DOI: 10.2337/diacare.12.2.156

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  3 in total

1.  No glucotoxicity after 53 hours of 6.0 mmol/l hyperglycaemia in normal man.

Authors:  H Flax; D R Matthews; J C Levy; S W Coppack; R C Turner
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

2.  Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.

Authors:  J C Levy; A Rudenski; M Burnett; R Knight; D R Matthews; R C Turner
Journal:  Diabetologia       Date:  1991-07       Impact factor: 10.122

3.  Precision and accuracy of hyperglycemic clamps in a multicenter study.

Authors:  Kieren J Mather; Ashley H Tjaden; Adam Hoehn; Kristen J Nadeau; Thomas A Buchanan; Steven E Kahn; Silva A Arslanian; Sonia Caprio; Karen M Atkinson; Melanie Cree-Green; Kristina M Utzschneider; Sharon L Edelstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-03-01       Impact factor: 4.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.